2020
DOI: 10.1186/s12885-020-07290-6
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of longitudinal transformation of T2-hyperintensity in oligodendroglioma

Abstract: Background: Oligodendroglioma (ODG) are CNS resistant tumors characterized by their unique molecular signature, namely a combined deletion of 1p and 19q simultaneously to an IDH1/2 mutation. These tumors have a more favorable clinical outcome compared to other gliomas and a long-time survival that ranges between 10 and 20 years. However, during the course of the disease, multiple recurrences occur and the optimal treatment at each stage of the disease remains unclear. Here we report a retrospective longitudina… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Diagnosis of GBM was based on the 2016 WHO Classification of Tumors of the Central Nervous System (17). Specimens were analyzed using the standard protocol at the Institute of Neuropathology, Medical Center-University of Freiburg as described in previous publications (17)(18)(19). IDH mutations were detected by immunohistochemistry (IHC).…”
Section: Histopathological and Molecular Analysismentioning
confidence: 99%
“…Diagnosis of GBM was based on the 2016 WHO Classification of Tumors of the Central Nervous System (17). Specimens were analyzed using the standard protocol at the Institute of Neuropathology, Medical Center-University of Freiburg as described in previous publications (17)(18)(19). IDH mutations were detected by immunohistochemistry (IHC).…”
Section: Histopathological and Molecular Analysismentioning
confidence: 99%
“…Specimens were fixed in 4% phosphate-buffered formaldehyde and paraffin-embedded according to standard procedures in the Institute of Neuropathology, Medical Center-University of Freiburg, as detailed described in our previous works [ 16 , 17 ]. In order to determine the IDH mutation status, we performed IHC (R132H).…”
Section: Methodsmentioning
confidence: 98%